Advisory Services Network’s Intellia Therapeutics NTLA Stock Holding History

Advisory Services Network’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33K	Buy	+2,575	New	+$32.8K	﹤0.01%	2888
2025 Q4	–	Sell	-1,889	Closed	-$32.6K	–	3435
2025 Q3	$32.6K	Buy	+1,889	New	+$23.3K	﹤0.01%	2711
2024 Q1	–	Sell	-1,577	Closed	-$48.1K	–	2898
2023 Q4	$48.1K	Buy	+1,577	New	+$45.3K	﹤0.01%	2033
2023 Q2	–	Sell	-1,261	Closed	-$47K	–	2870
2023 Q1	$47K	Sell	1,261 -195	-13%	-$7.65K	﹤0.01%	2055
2022 Q4	$50.8K	Buy	+1,456	New	+$69.2K	﹤0.01%	1966
2021 Q3	–	Sell	-200	Closed	-$32K	–	2601
2021 Q2	$32K	Buy	+200	New	+$15.6K	﹤0.01%	2236
2021 Q1	–	Sell	-300	Closed	-$16K	–	2403
2020 Q4	$16K	Buy	300 +292	+3,650%	+$10.6K	﹤0.01%	2231
2020 Q3	$0	Buy	+8	New	+$167	﹤0.01%	3613

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisory Services Network's NTLA Position: Q1 2026 in Review

Advisory Services Network opened a new position in Intellia Therapeutics (NTLA) in Q1 2026: 2,575 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #2888 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in NTLA as recently as Q3 2025.

Advisory Services Network first reported a position in NTLA in Q3 2020 and has held it in 8 quarters since. The position peaked at $50.8K in Q4 2022. 302 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

Advisory Services Network held 2,575 shares of Intellia Therapeutics worth $33K as of Q1 2026.
Intellia Therapeutics was a new Advisory Services Network position in Q1 2026.
Intellia Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2888 holding.
Advisory Services Network first reported a position in Intellia Therapeutics in Q3 2020 and has held it in 8 quarters since.
Advisory Services Network's Intellia Therapeutics position peaked at $50.8K in Q4 2022.
302 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.